Home » Newsletters » BioWorld Science

BioWorld Science

July 19, 2001

View Archived Issues

Peptides that stabilize protein antigens available for licensing from NIH

Corixa and Nycomed Amersham Imaging to copromote Metastron

PTC Therapeutics awarded SBIR grant to support HIV research

New pseudomycin prodrugs with superior therapeutic index

Positive phase II results for NBI-34060 in subjects with chronic insomnia

Major European launch for single-bolus thrombolytic

Discovery of novel classes of CFTR activators revealed by U. of California team

Novartis discovers potential new class of antidiabetic agents

Synthetic low-molecular-weight thrombin inhibitor and oral prodrug profiled at ISTH meeting

BTG commences phase I clinical trial of new anticancer agent

Nanogen Recognomics created from Nanogen-Aventis R&T collaboration

Inhibitor of vWF-collagen interaction effective in primate model of thrombosis

Ortec's wound-healing product to be marketed as OrCel; FDA advisory panel recommends approval

Antibody to high-molecular-weight kininogen effectively inhibits angiogenesis in tumor models

TransCell system demonstrates oral absorption in initial exploratory studies

Solvay advances cilansetron to phase III for IBS

Signature BioScience acquires Cambridge Discovery Chemistry from Millennium

Shorter treatment regimen for Valtrex approved by FDA

Baxter receives EMEA approval for Ceprotin

Promising preclinical antiangiogenic, antitumor activity described for PKCbeta inhibitor

Bristol-Myers Squibb and Exelixis focus on tumor suppressor genes

XTL and Dong Wha enter hepatitis C alliance

Therapy of psoriasis with anti-TNF-alpha antibodies

Antibacterial agents with additional pharmacological properties developed at Antex Pharma

2-Arylquinolines selectively relax urethral smooth muscle according to recent patent

Hormos presents new series of SERMs and their potential uses

Opioid receptor ligands designed by Palatin

Antiproliferative vitamin D analogues from Galderma particularly useful in dermatology

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for April 28, 2026.
Detecting the invisible: minimal residual disease at AACR 2026
BioWorld Science
Minimal residual disease (MRD) has become a central concept in modern oncology, reshaping how clinicians evaluate response, relapse risk and treatment precision....
News in brief
BioWorld Asia
BioWorld Asia briefs for April 28, 2026
Sichuan Kelun Pharmaceutical Research Institute discovers GPR6 inverse agonists
BioWorld Science
Sichuan Kelun Pharmaceutical Research Institute Co. Ltd. has identified G protein-coupled receptor 6 (GPR6) inverse agonists reported to be useful for the...
Grace Therapeutics hits CRL setback with GTx-104 despite positive trial
BioWorld
Grace Therapeutics Inc.’s hopes of becoming the first company in decades to update the standard of care in aneurysmal subarachnoid hemorrhage were delayed after...